{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T11:57:22Z","timestamp":1694519842048},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00347-015-0168-6","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T11:08:10Z","timestamp":1447326490000},"page":"409-415","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unkonservierte Glaukomtherapie"],"prefix":"10.1007","volume":"113","author":[{"given":"S.","family":"Pfennigsdorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Eschstruth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"key":"168_CR1","unstructured":"Abelson MB, Lafond A (2011) Glaucoma and dry eye: a tough combo. How chronic glaucoma treatment can give rise to ocular surface disease, and how you can treat them both. Rev Ophthalmol: 4 Oct 2011. http:\/\/www.revophth.com\/content\/d\/therapeutic_topics\/c\/30437\/ . Zugegriffen: 10. Juli 2012"},{"key":"168_CR2","unstructured":"DOG (2012) Stellungnahme der Deutschen Ophthalmologischen Gesellschaft zur Glaukomvorsorge, Stand 2012. http:\/\/www.dog.org\/wp-content\/uploads\/2009\/08\/Glaukomvorsorge-Stand-August-2012.pdf"},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jop.2008.0098","volume":"25","author":"SP Epstein","year":"2009","unstructured":"Epstein SP, Ahdoot M, Marcus E, Asbell PA (2009) Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 25:113\u2013119","journal-title":"J Ocul Pharmacol Ther"},{"key":"168_CR4","doi-asserted-by":"crossref","unstructured":"Erb C, Gast U, Schremmer D (2008) Deutsches Register f\u00fcr Glaukom-Patienten mit einem trockenen Auge \u2013 Ergebnisse von \u00fcber 20.000 Patienten. Klin Monatsbl Augenheilkd 225 \u2013 V18. doi:10.1055\/s-0028-1104699","DOI":"10.1055\/s-0028-1104699"},{"key":"168_CR5","unstructured":"European Medicines Agency (2009) EMEA Public Statement on antimicrobial preservatives in ophthalmologic preparations for human use. Doc. Ref.: EMEA\/622721\/2009"},{"key":"168_CR6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268\u20131279","journal-title":"Arch Ophthalmol"},{"key":"168_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"N Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P et al (2007) Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341\u2013349","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"168_CR8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajo.2009.12.003","volume":"149","author":"LJ Katz","year":"2010","unstructured":"Katz LJ, Cohen JS, Batoosingh AL et al (2010) Twelve-month, randomized, controlled trial of bimatoprost 0.01\u2009%, 0.0125\u2009%, and 0.03\u2009% in patients with glaucoma or ocular hypertension. Am J Ophthalmol 149(4):661\u2013671","journal-title":"Am J Ophthalmol"},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s00347-012-2636-6","volume":"109","author":"GK Krieglstein","year":"2012","unstructured":"Krieglstein GK (2012) Konservanzien in Ophthalmologika. Ophthalmologe 109:1062\u20131063","journal-title":"Ophthalmologe"},{"key":"168_CR10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"EW Leung","year":"2008","unstructured":"Leung EW, Medeiros FA, Weinreb RN (2008) Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 17:350\u2013355","journal-title":"J Glaucoma"},{"key":"168_CR11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","volume":"118","author":"SE Moss","year":"2000","unstructured":"Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264\u20131268","journal-title":"Arch Ophthalmol"},{"key":"168_CR12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"PJ Pisella","year":"2002","unstructured":"Pisella PJ, Pouliquen P, Baudouin C (2002) Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86:418\u2013423","journal-title":"Br J Ophthalmol"},{"key":"168_CR13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262","journal-title":"Br J Ophthalmol"},{"key":"168_CR14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","volume":"19","author":"GC Rossi","year":"2009","unstructured":"Rossi GC, Tinelli C, Pasinetti GM et al (2009) Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol 19:572\u2013579","journal-title":"Eur J Ophthalmol"},{"key":"168_CR15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ajo.2012.01.018","volume":"153","author":"SE Skalicky","year":"2012","unstructured":"Skalicky SE, Goldberg I, McCluskey P (2012) Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol 153:1003 (author reply 1003\u20131004)","journal-title":"Am J Ophthalmol"},{"key":"168_CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5301\/ejo.5000270","volume":"23","author":"I Stalmans","year":"2013","unstructured":"Stalmans I, M\u00e9gevand SG, Cordeiro MF et al (2013) Preservative-free treatment in glaucoma: who, when, and why. Eur J Ophthalmol 23:518\u2013525","journal-title":"Eur J Ophthalmol"},{"key":"168_CR17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ico.0000220776.93852.d9","volume":"25","author":"JH Tsai","year":"2006","unstructured":"Tsai JH, Derby E, Holland EJ, Khatana AK (2006) Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea 25:530\u2013532","journal-title":"Cornea"},{"key":"168_CR18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.84.8.856","volume":"84","author":"LM Beek Van","year":"2000","unstructured":"Van Beek LM, Keizer RJ de, Polak BC et al (2000) Incidence of ocular side effects of topical \u03b2 blockers in the Netherlands. Br J Ophthalmol 84:856\u2013859","journal-title":"Br J Ophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-015-0168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-015-0168-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-015-0168-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T13:23:04Z","timestamp":1567344184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-015-0168-6"}},"subtitle":["Wahl der richtigen Therapie in 1\u00a0min"],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1007\/s00347-015-0168-6","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]}}}